GGrantIndex
← Search

Cosmc - A Novel Molecular Chaperone Regulating O-Glycans

$290,143R01FY2008GMNIH

Emory University, Atlanta GA

Investigators

Linked publications & trials

Abstract

DESCRIPTION (provided by applicant): Human core 1 beta3-galactosyltransferase (T-synthase) generates the core 1 O-glycan Galbeta1 3GalNAc-alpha1-Ser/Thr or T-antigen, which is a precursor for many extended O-glycans in animal glycoproteins. Lack of T-synthase activity leads to expression of the Tn antigen GalNAc-alpha 1 -Ser/Thr, a common tumor associated antigen. This application arises from our discovery that T-synthase activity in cells requires the co-expression of a unique protein that we termed Cosmc (COre 1 beta3-Gal-T Specific Molecular Chaperone). Cosmc may be a unique chaperone primarily involved in folding and maturation of T-synthase. Cosmc is X-linked (Xq23) and its Cdna predicts a 318 amino acid transmembrane protein (approximately 36.4 kDa polypeptide size) with type-II membrane topology. Both human lymphoblastoid Jurkat and LSC colon carcinoma cell lines contain a normal gene and mRNA encoding T-synthase, but lack T-synthase activity. However, both cell lines contain a mutated, non-functional Cosmc; expression of wild-type Cosmc cDNA in both cell lines restores T-synthase activity and T-antigen expression. In cells lacking Cosmc, newly synthesized T-synthase is targeted to proteasomes for degradation. Cosmc binds ATP, consistent with a chaperone function, and Cosmc is primarily localized in the ER and Tsynthase is primarily in the Golgi. We hypothesize that Cosmc acts as a specific molecular chaperone in assisting the folding, stability, and/or targeting of T-synthase. To test this hypothesis we propose three specific aims. Aim 1 - We will define the subcellular localization of Cosmc and T-synthase and explore the mechanisms of Cosmc localization and its potential chaperone/escort function. Aim 2 - We will define whether Cosmc assists other glycosyltransferases and define its potential interaction with T-synthase and/or other proteins (e.g. chaperones) and ATP. Aim 3 - To define other possible biological functions of Cosmc and directly test our hypothesis, we will generate mice containing conventional and targeted, endothelial cell-specific deletions of Cosmc. An understanding of the structure and function of Cosmc should provide important new insights into the molecular basis of several human diseases, including IgA nephropathy, Tn-Syndrome, Henoch-Schonlein purpura, and malignant transformation associated with Tn antigen expression and lack of T-synthase activity.

View original record on NIH RePORTER →